These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 6183902)
81. Dose-dependent acute hepatitis associated with administration of high dose methotrexate. Banerjee AK; Lakhani S; Vincent M; Selby P Hum Toxicol; 1988 Nov; 7(6):561-2. PubMed ID: 3229766 [No Abstract] [Full Text] [Related]
82. Pulmonary toxicity in mice after high-dose methotrexate administration with and without leucovorin rescue. Pesce C; Mansi C; Bogliolo G; Tobia F; Pannacciulli I Eur J Cancer Clin Oncol; 1985 Jul; 21(7):875-80. PubMed ID: 3876219 [TBL] [Abstract][Full Text] [Related]
83. High dose intravenous methotrexate and reversible focal neurological deficit. Savage MW; Raguram CP; Rogers S; Scarffe JH; Morgenstern GR Br J Haematol; 1990 Dec; 76(4):558-9. PubMed ID: 2265121 [No Abstract] [Full Text] [Related]
84. Bone-marrow toxicity of methotrexate: a reassessment. Douglas ID; Price LA Br J Haematol; 1973 May; 24(5):625-31. PubMed ID: 4514552 [No Abstract] [Full Text] [Related]
85. Intermittent high dose oral methotrexate therapy in psoriasis. Baker H Br J Dermatol; 1970 Jan; 82(1):65-9. PubMed ID: 5410994 [No Abstract] [Full Text] [Related]
86. Biochemical and pathophysiological rationale for amethopterin in psoriasis. Weinstein GD Ann N Y Acad Sci; 1971 Nov; 186():452-66. PubMed ID: 5289429 [No Abstract] [Full Text] [Related]
87. Cyclosporine and methotrexate: a dangerous combination. Korstanje MJ; van Breda Vriesman CJ; van de Staak WJ J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):320-1. PubMed ID: 2212132 [No Abstract] [Full Text] [Related]
88. Impact of methotrexate therapy on the folate status of psoriatic patients. Hendel J; Nyfors A Clin Exp Dermatol; 1985 Jan; 10(1):30-5. PubMed ID: 3987083 [No Abstract] [Full Text] [Related]
89. Treatment of psoriasis with methotrexate and folinic acid. Burkhart CG J Am Acad Dermatol; 1980 Aug; 3(2):207-8. PubMed ID: 6967877 [No Abstract] [Full Text] [Related]
90. High-dose methotrexate therapy--an area of uncertainty. Paxton JW Aust N Z J Med; 1979 Dec; 9(6):722-32. PubMed ID: 394737 [No Abstract] [Full Text] [Related]
91. Liver biopsy in psoriasis. A controlled study. Zachariae H; Sogaard H Dermatologica; 1973; 146(3):149-55. PubMed ID: 4717481 [No Abstract] [Full Text] [Related]
92. Absorption of methotrexate and hepatotoxicity. Dubin HV; Harrell ER JAMA; 1969 Nov; 210(6):1104. PubMed ID: 5394437 [No Abstract] [Full Text] [Related]
93. Azaribine in the treatment of psoriasis. Dubin HV; Harrell ER Ann Intern Med; 1971 May; 74(5):797-8. PubMed ID: 5559450 [No Abstract] [Full Text] [Related]
94. Acute methotrexate toxicity in a patient with psoriasis: a case report. Abouzahir H; Belhouss A; Benyaich H Pan Afr Med J; 2024; 47():19. PubMed ID: 38524110 [TBL] [Abstract][Full Text] [Related]
95. Cyclosporin versus methotrexate toxicity in psoriasis. Zachariae H; Kragballe K Lancet; 1990 Apr; 335(8694):924. PubMed ID: 1970018 [No Abstract] [Full Text] [Related]
96. Systemic absorption of a leucovorin mouth wash: a pharmacologic study. Fiore JJ; Kemeny NE; Mehta BM; Geller N; Grossano D; Murphy D Cancer Invest; 1987; 5(2):109-11. PubMed ID: 3496943 [TBL] [Abstract][Full Text] [Related]